drugset / Trial / NCT03842800
Characterizing Clinical and Pharmacological Neuroimaging Biomarkers
Non-randomizedParallel-groupSingle-blindBasic science
Summary
This study is part of a larger overall study that seeks to characterize clinical and pharmacological neuroimaging biomarkers. The purpose of this registered protocol is understand the effect of emotion on cognitions by specifically examining the effect of reward processing on working memory in patients with schizophrenia.
Timeline
- Start
- 2013-04-01
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | — | — |